@entity23232 XXXX and @entity884 treated with @entity7048 and @entity1215 .

@entity1 @entity7048 @entity1353 @entity886 @entity281 @entity1576 @entity1215 @entity158 @entity23232 @entity2259 @entity884
PURPOSE: This case report describes the treatment of a rare @entity281 caused by @entity23232 with @entity7048 and @entity1215 . SUMMARY: A 48-year-old @entity1 with significant comorbidities was admitted to our institution with complaints of malaise, @entity1353 , and vague persistent @entity158 . He was diagnosed with @entity23232 @entity884 and was treated with @entity7048 continuous infusion for 10 days without resolution of @entity2259 . As surgical intervention was deemed inappropriate, @entity1215 was added to the treatment regimen for its antibiofilm activity. After @entity1215 initiation, resolution of @entity2259 was rapidly achieved. Subsequent blood cultures remained negative, and the @entity1 was discharged home in stable condition to complete six weeks of i.v. @entity7048 and @entity1215 therapy. The @entity1 continued treatment, as documented by the infusion center, weekly for five weeks. The @entity1 was rehospitalized during his sixth week of treatment due to impending @entity1576 , whereupon he was intubated and admitted to the intensive care unit. The @entity1 's cardiac status gradually worsened over the following days, and he ultimately died. Blood cultures from days 1 and 2 of hospitalization revealed no bacterial growth at five days. CONCLUSION: @entity7048 and @entity1215 therapy in a hospitalized @entity1 with @entity2259 and @entity886 caused by @entity23232 resulted in rapid eradication of the @entity2259 . After more than five weeks of @entity7048 - @entity1215 treatment, the @entity1 was rehospitalized with worsening cardiac function and died. Blood cultures during the second admission were negative.
